go to contents

a:head bio AG

Back to list

Facts

Founded
2019
Staff
9
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.

Similar companies in RDM biotech/pharma

AbbVie GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Phoenestra GmbH

Organization type
RDM biotech/pharma
Region
Upper Austria
Cluster
Medical Technology Cluster
Focus
human health
Details

piCHEM Forschungs- und Entwicklungs GmbH

Organization type
RDM biotech/pharma
Region
Styria
Cluster
Human.technology Styria
Focus
non-specific applications
Details

QUANTRO Therapeutics GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna

Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website